On the inhibition of cytochrome P450 3A4 by structurally diversified flavonoids

被引:1
|
作者
Mitrasinovic, Petar M. [1 ]
机构
[1] Belgrade Inst Sci & Technol, Ctr Biophys & Chem Res, Belgrade 11060, Serbia
来源
关键词
CYP3A4; cytochrome P450; 3A4; enzyme; flavonoid; inhibition; QM/MM; SCCDFTB-D; DENSITY-FUNCTIONAL-THEORY; INTERACTION ENERGIES; TIGHT-BINDING; BASE-PAIRS; DISPERSION; CYP3A4; COMPLEXES; IMPLEMENTATION; SIMULATIONS; METABOLISM;
D O I
10.1080/07391102.2021.1932603
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 3A4 (CYP3A4) is the most versatile enzyme involved in drug metabolism. The timedependent inhibition of CYP3A4 by acacetin, apigenin, chrysin, and pinocembrin was experimentally detected, but not entirely elaborated so far. Thus, a two-level QM/MM (Quantum Mechanics/Molecular Mechanics) model is developed to yield insights into the receptor-flavonoid recognition at the molecular scale. Active site residues and the flavonoid are modelled using SCC-DFTB-D (QM level), while the rest of the complex is treated using AMBER force field (MM level). QM/MM binding free energies are well correlated with experimental data, indicating the largest inhibitory effect of chrysin on enzyme activity at a submicromolar concentration. Consequently, quercetin (QUE) and flavopiridol (FLP) are observed as representative examples of structurally different flavonoids. The inhibition parameters for QUE and FLP are evaluated using the well-calibrated QM/MM strategy, thereby aiding to quantitatively conceive the functional behavior of the whole family of flavonoids. A kinetic threshold for further assessment of the drug-drug interactions underlying the time-dependent inhibition of CYP3A4 by flavonoids is explored.
引用
收藏
页码:9713 / 9723
页数:11
相关论文
共 50 条
  • [41] Anthocyanins and their metabolites are weak inhibitors of cytochrome P450 3A4
    Dreiseitel, Andrea
    Schreier, Peter
    Oehme, Anett
    Locher, Sanja
    Hajak, Goeran
    Sand, Philipp G.
    MOLECULAR NUTRITION & FOOD RESEARCH, 2008, 52 (12) : 1428 - 1433
  • [42] Kinetics and thermodynamics of ligand binding by cytochrome P450 3A4
    Isin, EM
    Guengerich, FP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (14) : 9127 - 9136
  • [43] Taurine modulates catalytic activity of cytochrome P450 3A4
    Shumyantseva, V. V.
    Makhova, A. A.
    Bulko, T. V.
    Bernhardt, R.
    Kuzikov, A. V.
    Shich, E. V.
    Kukes, V. G.
    Archakov, A. I.
    BIOCHEMISTRY-MOSCOW, 2015, 80 (03) : 366 - 373
  • [44] Antiprogestin-mediated inactivation of cytochrome P450 3A4
    Jang, GR
    Benet, LZ
    PHARMACOLOGY, 1998, 56 (03) : 150 - 157
  • [45] Cytochrome P450 3A4 activity after surgical stress
    Haas, CE
    Kaufman, DC
    Jones, CE
    Burstein, AH
    Reiss, W
    CRITICAL CARE MEDICINE, 2003, 31 (05) : 1338 - 1346
  • [46] Regioselectivity preference of testosterone hydroxylation by cytochrome P450 3A4
    Zhang, Yan
    Morisetti, Phani
    Kim, Jeffery
    Smith, Lynelle
    Lin, Hai
    THEORETICAL CHEMISTRY ACCOUNTS, 2008, 121 (5-6) : 313 - 319
  • [47] Involvement of human cytochrome P450 3A4 in the metabolism of vamidothion
    Mehmood, Z
    Kelly, DE
    Kelly, SL
    PESTICIDE SCIENCE, 1996, 46 (03): : 287 - 290
  • [48] Peripheral Ligand Binding and Allostery in Cytochrome P450 3A4
    Davydov, Dmitri R.
    Rumfeldt, Jessica A. O.
    Sineva, Elena V.
    Davydova, Nadezhda Y.
    Halpert, James R.
    FASEB JOURNAL, 2012, 26
  • [49] Approaches for increasing the electrocatalitic efficiency of cytochrome P450 3A4
    Shumyantseva, Victoria V.
    Koroleva, Polina I.
    Bulko, Tatiana, V
    Shkel, Tatyana, V
    Gilep, Andrei A.
    Veselovsky, Alexander V.
    BIOELECTROCHEMISTRY, 2023, 149
  • [50] Structural features of midazolam allostery by cytochrome P450 3A4
    Roberts, Arthur G.
    DRUG METABOLISM REVIEWS, 2011, 43 : 70 - 70